Therapeutic Drug Monitoring in Rheumatic Diseases
Keyword(s):
Abstract The ultimate goal of treating rheumatic disease is to achieve rapid suppression of inflammation, while at the same time minimizing the toxicities from rheumatic drugs. Different patients have different individual pharmacokinetics that can affect the drug level. Moreover, different factors, such as renal function, age or even different underlying diseases, can affect the drug level. Therefore, giving the same dosage of drugs to different patients may result in different drug levels. This article will review the usefulness of therapeutic drug monitoring in maximizing drug efficacy, while reducing the risk of toxicities in Hydroxychloroquine, Mycophenolate Mofetil, Tacrolimus and Tumor Necrosis Factor inhibitors (TNF Inhibitors).
2012 ◽
Vol 10
(10)
◽
pp. 1079-1087
◽
2020 ◽
Vol 14
(Supplement_1)
◽
pp. S488-S488
Keyword(s):
2017 ◽
Vol 23
(9)
◽
pp. 1510-1515
◽